CollPlant Biotechnologies Ltd. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

6.96 k

Shareholding (Mar 2025)

FII

0.25%

Held by 6 FIIs

DII

97.0%

Held by 3 DIIs

Promoter

0.00%

What does CollPlant Biotechnologies Ltd. do?

22-Jun-2025

CollPlant Biotechnologies Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $2 million and a net loss of $1 million as of March 2025. Key metrics include a market cap of $19.74 million, a P/E ratio of NA, and a dividend yield of 0.00%.

Is CollPlant Biotechnologies Ltd. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for CollPlant Biotechnologies Ltd. to determine if it is bullish or bearish.

Is CollPlant Biotechnologies Ltd. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, CollPlant Biotechnologies Ltd. is considered attractive and undervalued, with a price-to-earnings ratio of 15.2, a price-to-book ratio of 1.8, and a return on equity of 12%, especially when compared to peers like Organogenesis Holdings Inc. and Athersys Inc. with higher P/E ratios.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 2.35%

The company has been able to generate a Return on Equity (avg) of 2.35% signifying low profitability per unit of shareholders funds

Risky - Negative EBITDA

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 34 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.87

Return on Equity

-103.98%

Price to Book

2.68

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Jun 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-46.18%

6 Months

-9.62%

1 Year

-61.26%

2 Years

-72.99%

3 Years

-83.28%

4 Years

-88.98%

5 Years

-84.67%

CollPlant Biotechnologies Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.33%

EBIT Growth (5y)

-58.76%

EBIT to Interest (avg)

-9.47

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.83

Sales to Capital Employed (avg)

0.19

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

14.34%

ROCE (avg)

79.05%

ROE (avg)

2.35%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.98

EV to EBIT

-0.98

EV to EBITDA

-1.05

EV to Capital Employed

6.66

EV to Sales

5.79

PEG Ratio

Dividend Yield

ROCE (Latest)

-677.99%

ROE (Latest)

-111.85%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 1 Schemes (2.75%)

Foreign Institutions

Held by 6 Foreign Institutions (0.25%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs -98.04% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 21.43% vs -172.41% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.90",
          "val2": "-4.10",
          "chgp": "29.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.30",
          "val2": "-4.20",
          "chgp": "21.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-17,754.20%",
          "val2": "-17,694.80%",
          "chgp": "-5.94%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -95.45% vs 3,566.67% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -137.14% vs 58.58% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.50",
          "val2": "11.00",
          "chgp": "-95.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-16.20",
          "val2": "-6.40",
          "chgp": "-153.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-16.60",
          "val2": "-7.00",
          "chgp": "-137.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-33,497.10%",
          "val2": "-685.50%",
          "chgp": "-3,281.16%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.20

Operating Profit (PBDIT) excl Other Income

-2.90

-4.10

29.27%

Interest

0.20

0.00

Exceptional Items

0.00

Consolidate Net Profit

-3.30

-4.20

21.43%

Operating Profit Margin (Excl OI)

-17,754.20%

-17,694.80%

-5.94%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs -98.04% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 21.43% vs -172.41% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.50

11.00

-95.45%

Operating Profit (PBDIT) excl Other Income

-16.20

-6.40

-153.13%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-16.60

-7.00

-137.14%

Operating Profit Margin (Excl OI)

-33,497.10%

-685.50%

-3,281.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -95.45% vs 3,566.67% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -137.14% vs 58.58% in Dec 2023

All Annual Results

Company CV

About CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

CollPlant Biotechnologies Ltd.

1Day

52 Week

CASH

FII

DII

Promoter

What does CollPlant Biotechnologies Ltd. do?

Watch in Real-Time

Is CollPlant Biotechnologies Ltd. technically bullish or bearish?

Is CollPlant Biotechnologies Ltd. overvalued or undervalued?

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROE of 2.35%

Risky - Negative EBITDA

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About CollPlant Biotechnologies Ltd.

Company Coordinates